MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) has received an average rating of “Moderate Buy” from the ten research firms that are currently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average twelve-month target price among […]
Shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) were up 2% on Friday . The stock traded as high as $63.13 and last traded at $62.70. Approximately 113,153 shares changed hands during trading, a decline of 78% from the average daily volume of 526,207 shares. The stock had previously closed at $61.48. Analysts Set […]
MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report)’s share price gapped up prior to trading on Friday . The stock had previously closed at $55.25, but opened at $56.50. MoonLake Immunotherapeutics shares last traded at $55.60, with a volume of 12,281 shares changing hands. Analyst Ratings Changes Several research firms recently commented on MLTX. Bryan, Garnier […]
MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report)’s stock price was up 7.6% during mid-day trading on Thursday . The company traded as high as $46.31 and last traded at $45.52. Approximately 125,240 shares changed hands during trading, a decline of 76% from the average daily volume of 517,483 shares. The stock had previously closed at […]
MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report)’s share price was up 8% during mid-day trading on Wednesday after the company announced better than expected quarterly earnings. The stock traded as high as $40.92 and last traded at $40.41. Approximately 449,864 shares traded hands during trading, a decline of 13% from the average daily volume of […]